Saladaga, Baby Girl Ii .
HRN: 23-53-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
08/16/2023
08/22/2023
IVTT
12.5mg
Q24h
Potentially Septic Newborn, Omphalitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes